Skip to content
healthcare.dev

Lacosamide

NDC 10135-799, Lacosamide, tablet, film coated, from Marlex Pharmaceuticals, Inc.

Product NDC
10135-799
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218014
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-799 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE50 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
10135-799-601013507996060 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (10135-799-60)
10135-799-86101350799866 BLISTER PACK in 1 CARTON (10135-799-86) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0a273024-c2d2-4fae-90c3-b2f38a323f24

Use it

Look up 10135-799 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-799 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-799. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.